Ted W. Love
2021
In 2021, Ted W. Love earned a total compensation of $8.2M as President, Chief Executive Officer and Director at Global Blood Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $343,000 |
|---|---|
| Option Awards | $3,767,745 |
| Salary | $715,833 |
| Stock Awards | $3,360,731 |
| Other | $6,000 |
| Total | $8,193,309 |
Love received $3.8M in option awards, accounting for 46% of the total pay in 2021.
Love also received $343K in non-equity incentive plan, $715.8K in salary, $3.4M in stock awards and $6K in other compensation.
Rankings
In 2021, Ted W. Love's compensation ranked 1,404th out of 12,415 executives tracked by ExecPay. In other words, Love earned more than 88.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,404 out of 12,415 | 89th |
Division Manufacturing | 505 out of 5,505 | 91st |
Major group Chemicals And Allied Products | 186 out of 2,375 | 92nd |
Industry group Drugs | 155 out of 2,096 | 93rd |
Industry Pharmaceutical Preparations | 104 out of 1,546 | 93rd |
Pay ratio
| Ted W. Love's Pay | $8,193,309 |
|---|---|
| Median Employee's Pay | $345,973 |
| Pay Ratio | 24to 1 |
In 2021, the annual total compensation of Ted W. Love was $8,193,309.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of Ted W. Love's pay to the pay of median employee was therefore 24 to one.
Source: SEC filing on April 28, 2022.
Love's colleagues
We found four more compensation records of executives who worked with Ted W. Love at Global Blood Therapeutics in 2021.